|
業務類別
|
Biotechnology |
|
業務概覽
|
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability. |
| 公司地址
| 2051 Ringwood Avenue, San Jose, CA, USA, 95131 |
| 電話號碼
| +1 408 457-3700 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.ranitherapeutics.com |
| 員工數量
| 106 |
| Mr. Eric Groen |
General Counsel |
-- |
16/04/2025 |
| Dr. Mir Hashim, PhD |
Chief Scientific Officer |
美元 416.00K |
16/04/2025 |
| Mr. Talat Imran |
Chief Executive Officer and Director |
美元 105.82K |
16/04/2025 |
| Mr. Svai Sanford |
Chief Financial Officer and Principal Accounting Officer |
美元 416.00K |
16/04/2025 |
| Ms. Kate McKinley |
Chief Business Officer |
-- |
16/04/2025 |
|
|
| Ms. Lisa Ann Rometty |
Independent Director |
16/04/2025 |
| Mr. Mir Imran |
Chairman of the Board |
16/04/2025 |
| Mr. Talat Imran |
Chief Executive Officer and Director |
16/04/2025 |
| Dr. Dennis A. Ausiello, M.D. |
Independent Director |
16/04/2025 |
| Mr. Jean-Luc Butel |
Independent Director |
16/04/2025 |
| Dr. Vasudev Bailey, PhD |
Director |
27/10/2025 |
| Mr. Abraham Bassan |
Director |
27/10/2025 |
|
|
|
|
